initial public offerings (IPOs) trading on American exchanges

Wednesday, October 28, 2020

Biodesix (BDSX) began trading on the Nasdaq on Wed 28 Oct 20

Biodesix offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis.
Biodesix priced 4 mln share IPO at $18.00 per shaer, in-line with the expected range of $17-19

No comments:

Post a Comment